Amylyx Pharmaceuticals AMLX Balance Sheet (2021-2026)

NASDAQ AMLX
$38.60 +3.49 (+9.94%)
At close: Aug 19, 2026 · 4:00 PM UTC
1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation (Quarter)
0.05M0.54M1.63M1.36M1.55M
Assets
Current Assets
Cash & Equivalents (Quarter)
50.19M110.40M67.44M107.73M62.53M114.56M247.76M135.26M170.20M170.55M75.00M71.84M77.39M59.76M58.09M225.18M226.65M229.14M49.33M
Receivables - Net (Quarter)
0.14M15.31M17.55M33.47M29.35M40.05M20.35M4.09M1.73M0.45M0.30M0.10M0.13M0.09M
Receivables - Other (Quarter)
0.50M0.30M0.80M0.10M0.50M0.30M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.50M
Receivables (Quarter)
0.14M15.81M17.86M34.27M29.45M40.55M20.65M4.19M1.83M0.55M0.40M0.20M0.23M0.19M
Raw Materials (Quarter)
0.41M7.15M
Work In Process (Quarter)
0.04M1.68M
Finished Goods (Quarter)
0.11M0.94M
Inventory (Quarter)
0.56M9.77M13.07M24.86M32.37M38.32M
Prepaid Assets (Quarter)
5.39M10.28M9.46M8.34M10.11M12.75M11.79M17.34M14.93M16.89M12.82M9.14M12.48M11.78M5.96M9.26M6.69M5.26M5.58M
Current Assets (Quarter)
104.95M265.49M216.14M172.20M382.13M389.05M427.39M434.11M464.67M410.53M326.72M245.26M189.43M216.14M186.89M353.38M323.67M285.02M256.34M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.47M1.29M1.86M2.12M2.61M2.56M2.64M2.76M2.69M2.46M1.47M1.25M0.96M0.82M0.45M0.40M0.31M0.21M0.20M
Other Non-Current Assets (Quarter)
0.19M0.40M0.46M0.46M0.70M0.72M0.47M0.48M0.70M0.49M0.48M1.44M0.02M0.01M1.45M2.50M0.98M2.50M2.50M
Non-Current Assets (Quarter)
0.66M8.95M9.10M9.24M9.32M18.91M26.19M32.47M52.79M6.92M5.44M5.45M4.20M3.53M7.71M9.36M8.97M8.58M8.23M
Assets (Quarter)
105.61M274.44M225.24M181.44M391.45M407.96M453.59M466.58M517.45M417.46M332.16M250.71M193.63M219.68M194.60M362.74M332.64M293.60M264.56M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
4.37M10.04M8.12M7.05M6.26M10.77M24.70M6.37M22.06M21.45M4.96M1.49M2.94M4.81M3.29M5.34M3.52M3.53M5.53M
Payables (Quarter)
4.37M10.04M8.12M7.05M6.26M10.77M24.70M6.37M22.06M21.45M4.96M1.49M2.94M4.81M3.29M5.34M3.52M3.53M5.53M
Accumulated Expenses (Quarter)
4.28M3.58M6.48M8.99M38.31M38.75M37.24M37.05M57.72M67.87M62.76M50.46M23.95M12.07M17.46M19.47M17.91M11.28M14.61M
Other Accumulated Expenses (Quarter)
0.26M0.44M0.54M0.36M1.00M
Current Leases (Quarter)
1.41M1.79M1.99M2.04M2.09M2.15M2.20M2.26M2.31M2.37M1.97M1.52M1.05M0.67M0.98M1.26M1.16M1.01M
Total Current Liabilities (Quarter)
17.40M27.71M27.16M32.65M46.61M51.62M64.08M45.62M82.04M91.64M70.08M53.91M28.41M17.93M21.42M25.79M22.69M15.97M21.15M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
0.04M
Preferred Stock Liabilities (Quarter)
134.79M134.79M
Operating Leases (Quarter)
5.79M5.29M4.77M4.24M3.69M3.14M2.57M1.98M1.38M0.77M5.10M0.46M0.33M5.30M4.95M4.70M4.48M4.25M
Other Non-Current Liabilities (Quarter)
1.36M
Total Non-Current Liabilities (Quarter)
49.49M
Total Liabilities (Quarter)
17.43M33.49M32.45M37.41M50.85M55.31M67.22M48.18M84.02M93.02M70.85M54.51M28.87M18.26M26.72M30.75M27.39M20.44M25.40M
Shareholder's Equity
Common Equity (Quarter)
-124.07M-151.17M240.95M192.79M144.03M340.61M352.65M386.37M418.40M433.43M324.44M261.31M196.20M164.76M201.42M167.88M332.00M305.26M273.16M239.17M
Liabilities and Shareholders Equity (Quarter)
105.61M274.44M225.24M181.44M391.45M407.96M453.59M466.58M517.45M417.46M332.16M250.71M193.63M219.68M194.60M362.74M332.64M293.60M264.56M
Retained Earnings (Quarter)
0.01M-203.70M-0.20M-311.50M-354.22M-352.65M-330.57M-0.15M0.20M-0.08M-0.10M-569.15M-606.69M-642.60M0.55M-718.43M-751.43M0.24M-836.13M
Treasury Shares (Quarter)
13.15M37.11M0.60M0.67M0.69M0.74M1.06M1.06M1.08M1.11M2.06M2.91M2.27M2.21M3.17M3.14M2.76M2.73M3.93M3.86M